Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07363525 · ClinicalTrials.gov registry record
Michigan Initial Experience Using Tigertriever for Thrombectomy
A clinical trial, sponsored by Henry Ford Health System.
- Recruiting
- Registry status
- 150
- Enrollment target
NCT07363525: Recruiting study, sponsored by Henry Ford Health System.
NCT07363525 is a clinical trial that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07363525 is actively recruiting participants, sponsored by Henry Ford Health System.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
Study Summary
The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in patients experiencing ischemic stroke within 8 hours of symptom onset.
Primary Outcome
Percentage of participants with a modified Rankin Scale (mRS) score ≤2
Interventions
- PROCEDURE Mechanical Thrombectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-01-15 |
| Est. Completion | 2028-12-31 |
What NCT07363525 shows while recruiting
NCT07363525 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Mechanical Thrombectomy is the first listed.
NCT07363525 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07363525 about?
NCT07363525 is a clinical study titled "Michigan Initial Experience Using Tigertriever for Thrombectomy". The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in ...
What is the current status of trial NCT07363525?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2026-01-15. Estimated completion is 2028-12-31.
What interventions are being tested in trial NCT07363525?
The interventions under investigation include: Mechanical Thrombectomy (PROCEDURE).
Who is sponsoring clinical trial NCT07363525?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI